pemetrexed disodium - search results

United States - English - NLM (National Library of Medicine)

pemetrexed- pemetrexed disodium injection, powder, lyophilized, for solution

bluepoint laboratories - pemetrexed disodium (unii: 2pku919ba9) (pemetrexed - unii:04q9aiz7no) - pemetrexed for injection is indicated: - in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous non-small cell lung cancer (nsclc), with no egfr or alk genomic tumor aberrations. - in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non-squamous nscl . - as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous nsclc whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. - as a single agent for the treatment of patients with recurrent, metastatic non-squamous, nsclc after prior chemotherapy. limitations of use: pemetrexed for injection is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer [see clinical studies ( 14.1)] . pemetrexed for in

United States - English - NLM (National Library of Medicine)

pemetrexed- pemetrexed disodium injection, powder, lyophilized, for solution

bluepoint laboratories - pemetrexed disodium (unii: 2pku919ba9) (pemetrexed - unii:04q9aiz7no) - pemetrexed for injection is indicated: - in combination with pembrolizumab and platinum chemotherapy, for the initial treatment of patients with metastatic non-squamous non-small cell lung cancer nsclc, with no egfr or alk genomic tumor aberrations. - in combination with cisplatin for the initial treatment of patients with locally advanced or metastatic, non- squamous, nsclc. - as a single agent for the maintenance treatment of patients with locally advanced or metastatic, non-squamous nsclc whose disease has not progressed after four cycles of platinum-based first-line chemotherapy. - as a single agent for the treatment of patients with recurrent, metastatic non-squamous, nsclc after prior chemotherapy. limitations of use: pemetrexed for injection is not indicated for the treatment of patients with squamous cell, non-small cell lung cancer [see clinical studies ( 14.1)] . pemetre

Canada - English - Health Canada

pemetrexed disodium for injection usp powder for solution

marcan pharmaceuticals inc - pemetrexed (pemetrexed disodium hemipentahydrate) - powder for solution - 100mg - pemetrexed (pemetrexed disodium hemipentahydrate) 100mg - antineoplastic agents

Canada - English - Health Canada